CTX131
CRSP-ONC-008
Phase 2 mab completed
Quick answer
CTX131 for T Cell Lymphoma is a Phase 2 program (mab) at CRISPR Therapeutics AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CRISPR Therapeutics AG
- Indication
- T Cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed